Cargando…

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer

BACKGROUND: There is a critical need for improved diagnostic markers for high grade serous epithelial ovarian cancer (SEOC). MicroRNAs are stable in the circulation and may have utility as biomarkers of malignancy. We investigated whether levels of serum microRNA could discriminate women with high-g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kan, Casina WS, Hahn, Michael A, Gard, Gregory B, Maidens, Jayne, Huh, Jung Yoon, Marsh, Deborah J, Howell, Viive M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542279/ https://www.ncbi.nlm.nih.gov/pubmed/23272653 http://dx.doi.org/10.1186/1471-2407-12-627

Ejemplares similares

Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing
por: Cole, Alexander J., et al.
Publicado: (2016)

Why the dual origins of high grade serous ovarian cancer matter
por: Colvin, Emily K., et al.
Publicado: (2020)

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
por: Yang, Junzheng, et al.
Publicado: (2017)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer
por: Hannan, Natalie J., et al.
Publicado: (2021)

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
por: Zakarya, Razia, et al.
Publicado: (2020)

MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer
por: Ibrahim, Fateen Farhana, et al.
Publicado: (2015)

The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015)

Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency
por: Cole, Alexander J., et al.
Publicado: (2017)

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
por: Moran-Jones, Kim, et al.
Publicado: (2015)

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
por: Zhu, Tingting, et al.
Publicado: (2020)

PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer
por: Dickson, Kristie-Ann, et al.
Publicado: (2021)

Cancer Cell Colonisation in the Bone Microenvironment
por: Kan, Casina, et al.
Publicado: (2016)

Expression of long noncoding RNAs in cancer‐associated fibroblasts linked to patient survival in ovarian cancer
por: Colvin, Emily K., et al.
Publicado: (2020)

Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer
por: Choi, Pui-Wah, et al.
Publicado: (2020)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
por: Vafaee, Fatemeh, et al.
Publicado: (2017)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Ovarian high-grade serous carcinoma with elevated β-human chorionic gonadotropin: A case report
por: Zhong, Yi, et al.
Publicado: (2021)

Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes
por: Feng, Ying, et al.
Publicado: (2022)

Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma
por: Ruano, Anna Paula Carreta, et al.
Publicado: (2022)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016)

The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells
por: Márton, Éva, et al.
Publicado: (2020)

Increased Intragenic IGF2 Methylation is Associated with Repression of Insulator Activity and Elevated Expression in Serous Ovarian Carcinoma
por: Huang, Zhiqing, et al.
Publicado: (2013)

Complete Laparoscopic Ovarian Cystectomy of Giant Ovarian Serous Cystadenoma
por: Prasad, Indira, et al.
Publicado: (2023)

Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer
por: Paracchini, Lara, et al.
Publicado: (2022)

Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients
por: Asante, Du-Bois, et al.
Publicado: (2023)

Herpes Virus MicroRNA Expression and Significance in Serous Ovarian Cancer
por: Pandya, Deep, et al.
Publicado: (2014)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

Culture Models to Define Key Mediators of Cancer Matrix Remodeling
por: Fuller, Emily Suzanne, et al.
Publicado: (2014)

Morphological and molecular basis of ovarian serous carcinoma
por: Rosen, Daniel G, et al.
Publicado: (2010)

Prediction of chemo-response in serous ovarian cancer
por: Gonzalez Bosquet, Jesus, et al.
Publicado: (2016)

Architectural Histopathological Changes in Ovarian Serous Carcinomas
por: DOCHIȚ, C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n5gocueqsa0qbor2h493a7trk9